Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toshiya Inaba

Showing results (81-90 of 90) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 90 results.
Blood|June 4, 2010
Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19)Kinuko Hirose, Takeshi Inukai, Jiro Kikuchi, et al.
Hematological Oncology|June 10, 2020
High prevalence of MEF2D fusion in human B-cell precursor acute lymphoblastic leukemia cell linesKoshi Akahane, Takahiko Yasuda, Shinobu Tsuzuki, et al.
Blood|November 11, 2020
UTX maintains the functional integrity of the murine hematopoietic system by globally regulating aging-associated genesYasuyuki Sera, Yuichiro Nakata, Takeshi Ueda, et al.
Leukemia|March 21, 2018
A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignanciesDaichi Inoue, Takeshi Fujino, Paul Sheridan, et al.
Blood|June 4, 2020
HHEX promotes myeloid transformation in cooperation with mutant ASXL1Reina Takeda, Shuhei Asada, Sung-Joon Park, et al.
Blood|June 24, 2020
Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALLAtsushi Watanabe, Kunio Miyake, Jessica Nordlund, et al.
Cancer Medicine|July 16, 2019
Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapyAtsushi Watanabe, Takeshi Inukai, Keiko Kagami, et al.
Blood Advances|March 4, 2020
Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient statusRaksha Shrestha, Mamiko Sakata-Yanagimoto, Koichiro Maie, et al.
Blood|June 16, 2022
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemiaAtsushi Tanaka, Taizo A Nakano, Masaki Nomura, et al.
Nature Communications|August 30, 2022
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemiaTomoya Isobe, Masatoshi Takagi, Aiko Sato-Otsubo, et al.
Pageof 9

Showing results (81-90 of 90) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 90 results.
Blood|June 4, 2010
Aberrant induction of LMO2 by the E2A-HLF chimeric transcription factor and its implication in leukemogenesis of B-precursor ALL with t(17;19)Kinuko Hirose, Takeshi Inukai, Jiro Kikuchi, et al.
Hematological Oncology|June 10, 2020
High prevalence of MEF2D fusion in human B-cell precursor acute lymphoblastic leukemia cell linesKoshi Akahane, Takahiko Yasuda, Shinobu Tsuzuki, et al.
Blood|November 11, 2020
UTX maintains the functional integrity of the murine hematopoietic system by globally regulating aging-associated genesYasuyuki Sera, Yuichiro Nakata, Takeshi Ueda, et al.
Leukemia|March 21, 2018
A novel ASXL1-OGT axis plays roles in H3K4 methylation and tumor suppression in myeloid malignanciesDaichi Inoue, Takeshi Fujino, Paul Sheridan, et al.
Blood|June 4, 2020
HHEX promotes myeloid transformation in cooperation with mutant ASXL1Reina Takeda, Shuhei Asada, Sung-Joon Park, et al.
Blood|June 24, 2020
Association of aberrant ASNS imprinting with asparaginase sensitivity and chromosomal abnormality in childhood BCP-ALLAtsushi Watanabe, Kunio Miyake, Jessica Nordlund, et al.
Cancer Medicine|July 16, 2019
Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapyAtsushi Watanabe, Takeshi Inukai, Keiko Kagami, et al.
Blood Advances|March 4, 2020
Molecular pathogenesis of progression to myeloid leukemia from TET-insufficient statusRaksha Shrestha, Mamiko Sakata-Yanagimoto, Koichiro Maie, et al.
Blood|June 16, 2022
Aberrant EVI1 splicing contributes to EVI1-rearranged leukemiaAtsushi Tanaka, Taizo A Nakano, Masaki Nomura, et al.
Nature Communications|August 30, 2022
Multi-omics analysis defines highly refractory RAS burdened immature subgroup of infant acute lymphoblastic leukemiaTomoya Isobe, Masatoshi Takagi, Aiko Sato-Otsubo, et al.
Pageof 9